Survival improvement in patients with pancreatic cancer by decade: A period analysis of the SEER database, 1981-2010

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Sun, Huanhuan ^a   Ma, Haiqing ^a   Hong, Guobin ^a   Sun, Hongliu ^b   Wang, Jin ^c  

^a THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER REGISTRY; HUMAN; MORTALITY; PANCREAS TUMOR; PATHOLOGY; SOCIOECONOMICS; SURVIVAL RATE;

HUMANS; PANCREATIC NEOPLASMS; SEER PROGRAM; SOCIOECONOMIC FACTORS; SURVIVAL RATE;

EID: 84938214580     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06747     Document Type: Article

References (29)

1. Muniraj, T., Jamidar, P. A. & Aslanian, H. R. Pancreatic cancer: a comprehensive review and update. Dis Mon 59, 368-402 (2013).
2. Gong, Z., Holly, E. A. & Bracci, P. M. Survival in population-based pancreatic cancer patients: San Francisco Bay area, 1995-1999. Am J Epidemiol 174, 1373-1381 (2011).
3. Wang, J. & Sen, S. MicroRNA functional network in pancreatic cancer: From biology to biomarkers of disease. J Biosci 36, 481-491 (2011).
4. Zell, J. A., Rhee, J. M., Ziogas, A., Lipkin, S. M. & Anton-Culver, H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidem Biomar 16, 546-552 (2007).
5. Riall, T. S. et al. Pancreatic cancer in the general population: Improvements in survival over the last decade. J Gastrointest Surg 10, 1212-1223 (2006).
6. Shaib, Y., Davila, J., Naumann, C. & El-Serag, H. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study. Am J Gastroenterol 102, 1377-1382 (2007).
7. Stessin, A. M., Meyer, J. E. & Sherr, D. L. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry. Int J Radiat Oncol Biol Phys 72, 1128-1133 (2008).
8. Chang, K. J., Parasher, G., Christie, C., Largent, J. & Anton-Culver, H. Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups. Cancer 103, 349-357 (2005).
9. Baine, M. et al. Marital status and survival in pancreatic cancer patients: a SEER based analysis. PLoS One 6, e21052 (2011).
10. Cheung, M. C. et al. Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma? Cancer 116, 723-733 (2010).
11. Shaib, Y. H., Davila, J. A. & El-Serag, H. B. The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther 24, 87-94 (2006).
12. Cress, R. D., Yin, D., Clarke, L., Bold, R. & Holly, E. A. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control 17, 403-409 (2006).
13. Baxter, N. N., Whitson, B. A. & Tuttle, T. M. Trends in the treatment and outcome of pancreatic cancer in the United States. Ann Surg Oncol 14, 1320-1326 (2007).
14. Regi, P. et al. Cystic "feminine" pancreatic neoplasms in men. Do any clinical alterations correlate with these uncommon entities? Int J Surg 11, 157-160 (2013).
15. Lee, E. et al. Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS. Am J Epidemiol 178, 1403-1413 (2013).
16. Wei, M. Y. & Giovannucci, E. L. Vitamin D and multiple health outcomes in the Harvard cohorts. Mol Nutr Food Res 54, 1114-1126 (2010).
17. Giovannucci, E. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 19, 84-88 (2009).
18. Grant, W. B. & Peiris, A. N. Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and white Americans. Dermatoendocrinol 4, 85-94 (2012).
19. Silverman, D. T. et al. Why do Black Americans have a higher risk of pancreatic cancer than White Americans? Epidemiology 14, 45-54 (2003).
20. National Center for Health Statistics. Health, United States, 2011: With Special Feature on Socioeconomic Status and Health (2012), www.cdc.gov/nchs/data/hus/hus11.pdf. [accessed Aug 19, 2014].
21. Sumi, C., Brinck-Johnsen, T. & Longnecker, D. S. Inhibition of a transplantable pancreatic carcinoma by castration and estradiol administration in rats. Cancer Res 49, 6687-6692 (1989).
22. Sumi, C., Longnecker, D. S., Roebuck, B. D. & Brinck-Johnsen, T. Inhibitory effects of estrogen and castration on the early stage of pancreatic carcinogenesis in Fischer rats treated with azaserine. Cancer Res 49, 2332-2336 (1989).
23. Murphy, M. M. et al. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma. Ann Surg Oncol 16, 2968-2977 (2009).
24. Krieger, N., Chen, J. T., Waterman, P. D., Rehkopf, D. H. & Subramanian, S. V. Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures-the public health disparities geocoding project. Am J Public Health 93, 1655-1671 (2003).
25. Krieger, N. et al. Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? the Public Health Disparities Geocoding Project. Am J Epidemiol 156, 471-482 (2002).
26. Surveillance, Epidemiology, and End Results (SEER) Program. Research data (1973-2010), www.seer.cancer.gov. National Cancer Institute, Division of Cancer Control and Population Services, Surveillance Research Program, Surveillance Systems Branch, released April 2014 [accessed Jun 19, 2014].
27. Singh, G. K., Miller, B. A., Hankey, B. F. & Edwards, B. K. Area Socioeconomic Variations In US Cancer Incidence, Mortality, Stage, Treatment, And Survival, 1975-1999. National Cancer Institute, Bethesda. Report No.:NIH PublicationNo. 03-5417 (2003).
28. Dickman, P. W. & Adami, H. O. Interpreting trends in cancer patient survival. J Intern Med 260, 103-117 (2006).
29. Hakulinen, T., Seppa, K. & Lambert, P. C. Choosing the relative survival method for cancer survival estimation. Eur J Cancer 47, 2202-2210 (2011).